Concepedia

Ali Raoof

AR

Statistics

Publications

8

Citations

544

H-Index

8

Active since

2001

Affiliations

Cancer Research UK Manchester Institute(Current)

University of Manchester

GlaxoSmithKline (United States)

University of Sussex

Ali Raoof is an author at Cancer Research UK Manchester Institute specializing in pharmacology, drug discovery, and medicine.

Publications per year

2001–2021

8

Publications

8

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

Melissa B. Pappalardi, Kathryn Keenan, Mark Cockerill et al. · Nature Cancer · 2021 · 280 citations · Full text

, , +8

<i>In vitro</i> and <i>in vivo</i> induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor

Aidan G. Gilmartin, Arthur Groy, Elizabeth R. Gore et al. · Haematologica · 2020 · 68 citations · Full text

, , +12

Toxoflavins and Deazaflavins as the First Reported Selective Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase II

Ali Raoof, Paul Depledge, Niall M. Hamilton et al. · Journal of Medicinal Chemistry · 2013 · 61 citations · Full text

, , +15

Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2

P. Hornyak, Trevor Askwith, Sarah Walker et al. · Biochemical Journal · 2016 · 37 citations · Full text

, , +14

Tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone initiates and enhances pancreatitis responses

Mehida Alexandre, Abdul Kareem Uduman, Samantha N. Minervini et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2012 · 32 citations

, , +10

1–5 of 8